EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer

Rita Nahta, Dihua Yu, Mien-Chie Hung, Gabriel N Hortobagyi, Francisco J Esteva

Nature Clinical Practice Oncology · 2006-05 · 3 (5) · 269-280

DOI: 10.1038/ncponc0509 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nature Clinical Practice Oncology, 2006-05. Verfasst von Rita Nahta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston 77030-4009, USA. rnahta@mdanderson.org. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm. Die Arbeit wurde bisher 691-mal zitiert (Crossref) und nennt 105 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsBreast NeoplasmsClinical Trials as TopicCyclin-Dependent Kinase Inhibitor p27FemaleHumansMembrane ProteinsNeoplasm InvasivenessPTEN PhosphohydrolasePhosphatidylinositol 3-KinasesProtein Kinase InhibitorsErb-b2 Receptor Tyrosine KinasesReceptor, IGF Type 1Signal TransductionTrastuzumab

Substanzen

Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsCyclin-Dependent Kinase Inhibitor p27Membrane ProteinsPTEN PhosphohydrolasePhosphatidylinositol 3-KinasesProtein Kinase InhibitorsErb-b2 Receptor Tyrosine KinasesReceptor, IGF Type 1

Autor:innen und Institutionen

  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston 77030-4009, USA. rnahta@mdanderson.org

Förderung

  • NCI NIH HHS

Zitieren

APA

Nahta, R., Yu, D., Hung, M. C., Hortobagyi, G. N., & Esteva, F. J. (2006). Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nature Clinical Practice Oncology, 3(5), 269-280. https://doi.org/10.1038/ncponc0509

Vancouver

Nahta R, Yu D, Hung MC, Hortobagyi GN, Esteva FJ. Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nature Clinical Practice Oncology. 2006;3(5):269-280. doi:10.1038/ncponc0509

BibTeX
@article{Nahta2006,
  author = {Nahta, Rita and Yu, Dihua and Hung, Mien-Chie and Hortobagyi, Gabriel N and Esteva, Francisco J},
  title = {Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer},
  journal = {Nature Clinical Practice Oncology},
  year = {2006},
  volume = {3},
  number = {5},
  pages = {269--280},
  doi = {10.1038/ncponc0509}
}
Kostenlos starten →